Product Details:
| Strength | 250 mg |
| Packaging Size | 1*6 Tablets |
| Packaging Type | Box |
| Brand | Azycap 250 |
| Manufacturer | Medlock healthcare |
| Shelf Life | 24 Months |
| Usages | To treat a variety of bacterial infections |
| Country of Origin | Made in India |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Minimum Order Quantity | 500 Vial |
| Packaging Size | 1.5 gm |
| Packaging Type | Vial |
| Shelf life | 24 months |
| Form | Injection |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 10000 Vial |
| Strength | 1 gm |
| Brand Name | Cefaxone |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| AVAILABLE | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 10000 Vial |
| Strength | 1.5 gm |
| Pack Type | Vial |
| Composition | Ceftriaxonen 1000mg + Sulbactam 500mg |
| Brand | XONMED SB-1.5 GM INJ |
| Shelf Life | 24 Months |
| AVAILABLE | MEDLOCKHEALTHCARE |
Product Details:
| Minimum Order Quantity | 10000 Vial |
| Strength | 375 mg |
| Composition | Ceftriaxonen 250mg + Sulbactam 125mg |
| Brand | XONMED SB 375 GM INJ |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| AVALABLE | MEDLOCK HEALTHVARE |
Product Details:
| Minimum Order Quantity | 10000 Piece |
| Strength | 1.125 MG |
| Brand Name | Cefaxone |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| AVAILABLE | MEDLOCK HEALTHACER |
Product Details:
| Strength | 1 gm |
| Pack Size | 20 ml |
| Pack Type | Vial |
| Brand Name | MEROLOC-1 GM INJECTION |
| Manufacturer | MEDLOCK HEALTHCARE |
| Usages | to treat infections caused by bacteria. |
| Prescription/Non Prescription | Prescription |
| Shelf Life | 24 MONTH |
| Also Gives | Third Party Manufacturing, PCD Pharma Franchise |
| Country of Origin | Made in India |
Product Details:
| Strength | 1.5GM |
| Pack Type | Vial |
| Brand Name | MEROLOC-SB INJECTION |
| Manufacturer | MEDLOCK HEALTHCARE |
| Usages | to treat bacterial infections such as skin infections, gynecological infections, and intra-abdominal |
| Prescription/Non Prescription | Prescription |
| Shelf Life | 24 MONTH |
| Also Gives | Third Party Manufacturing, PCD Pharma Franchise |
| Country of Origin | Made in India |
Product Details:
| Strength | 250 mg |
| Brand | MEROLOC-250 INJ |
| Form | Vial with WFI |
| Composition | Meropenem trihydrate |
| Route of Administration | IV |
| Packaging Size | 1 vial + WFI |
| Injection Type | Powder for injection |
| Pharmacopoeia Standard | IP |
| Usage | Human |
Meroloc-250 Injection is a broad-spectrum carbapenem antibiotic used to treat severe bacterial infections caused by susceptible organisms. It works by inhibiting bacterial cell wall synthesis, effectively eliminating the infection. Meropenem is active against a wide range of Gram-positive and Gram-negative bacteria, including multi-drug-resistant strains. It is particularly effective for infections where other antibiotics fail to deliver adequate results.
This injection is commonly prescribed for severe respiratory tract infections, complicated skin and soft tissue infections, urinary tract infections, intra-abdominal infections, and bacterial meningitis. Its efficacy and safety profile make it a reliable choice for treating life-threatening bacterial infections.
Product Details:
| Strength | 125 mg |
| Brand | MEROLOC-125 INJ |
| Form | Vial with WFI |
| Composition | Meropenem trihydrate |
| Route of Administration | IV |
| Packaging Size | 1 vial + WFI |
| Injection Type | Powder for injection |
| Pharmacopoeia Standard | IP |
| Usage | Human |
Meroloc-125 Injection contains Meropenem (125mg), a broad-spectrum carbapenem antibiotic used to treat a wide range of serious bacterial infections, including those caused by multidrug-resistant organisms. Meropenem works by inhibiting bacterial cell wall synthesis, making it highly effective against both Gram-positive and Gram-negative bacteria, including anaerobes. It is often used in hospitals for life-threatening or complicated infections.
It helps in the treatment of serious infections such as lower respiratory tract infections, intra-abdominal infections, skin and soft tissue infections, urinary tract infections, bacterial meningitis, and septicemia, particularly in critically ill or hospitalized patients.
Product Details:
| Strength | 500 mg |
| Brand | MEROLOC-500 INJ |
| Form | Vial with WFI |
| Composition | Meropenem trihydrate |
| Route of Administration | IV |
| Packaging Size | 1 vial + WFI |
| Injection Type | Powder for injection |
| Pharmacopoeia Standard | IP |
| Usage | Human |
Meroloc-500 Injection is a broad-spectrum antibiotic belonging to the carbapenem class. It is highly effective against a wide range of bacterial infections, including both gram-positive and gram-negative bacteria, as well as anaerobes. Meropenem inhibits bacterial cell wall synthesis, leading to cell death and eradication of the infection.
This medication is primarily used in the treatment of severe or complicated infections such as pneumonia, intra-abdominal infections, urinary tract infections, bacterial meningitis, and sepsis. Its potent activity against multidrug-resistant organisms makes it a critical choice for managing life-threatening infections.
Administered intravenously, Meropenem 500 Injection ensures rapid and effective treatment, with reliable distribution to infected tissues. It is often employed in hospital settings for patients who require immediate and potent antibacterial therapy.
Product Details:
| Strength | 500 mg |
| Packaging Size | 1*3 Tablets |
| Brand | Azycap 500 |
| Composition | Azithromycin Only |
| Dosage Form | Tablet |
| Packaging Type | Box |
| Manufacturer | Medlock Healthcare |
| Shelf Life | 24 Months |
| Prescription Required | Yes |
| Medicine Type | Branded |
| Country of Origin | Made in India |
| Available | PCD PHARMA FRANCHISE |
Azithromycin 500 mg tablets are oral macrolide antibiotics used to treat various bacterial infections—including respiratory, skin, and sexually transmitted diseases—by inhibiting bacterial protein synthesis, typically administered once daily for 3-5 days. It is highly effective against pneumonia and bronchitis, but it is not effective against viral infections like the cold or flu.
Key Details for Azithromycin 500 mg Tablets:
Product Details:
| Strength | 200 mg |
| Pack Size | 10*10 Capsule |
| Pack Type | Box |
| Brand | LOCPOD-200 |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Pack Size | 1*6 Capsule |
| Pack Type | Box |
| Brand | LOCPOD CV 325 |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| Country of Origin | Made in India |
| Available | MEDLOCK HEALTHCARE |
| Strength | 325 mg |
Product Details:
| Strength | 500mg |
| Packaging Type | Alu-Alu |
| Packaging Size | 10*10 Tablets |
| Brand | LEVOLOCK-500 |
| Manufacturer | MEDLOCK HEALTHCARE |
| Usage / Application | Hospital |
Product Details:
| Dose | 500 mg/ 2ml |
| Packaging Type | Vial |
| Form | Injection |
| Shelf life | 24 months |
| Prescription/Non prescription | Prescription |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Pack Size | 10*5 |
| Pack Type | Strips |
| Strength | 400 mg |
| Brand Name | NAVIMOCX-400 TABLET |
| Manufacturer | MEDLOCK HEALTH CARE |
| Usages | ANTIBIOTIC |
| Country of Origin | Made in India |
Product Details:
| Strength | 250mg |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Box |
| Brand | ROXILOC-250 |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| Usage | To treat bacterial infections |
| Country of Origin | Made in India |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Strength | 500mg |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Box |
| Brand | ROXILOCK-500 |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| Usage | To treat bacterial infections |
| Country of Origin | Made in India |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Strength | 4.5 g |
| Pack Type | Vial |
| Composition | Piperacillin 4000MG Tazobactam 500MG Injection |
| Brand Name | MEDPIP 4.5 INJECTION |
| Usages | Piperacillin and tazobactam combination injection is used to treat bacterial infections in many diff |
| Shelf Life | 24 MONTH |
| Prescription | Prescription |
| Country of Origin | Made in India |
Product Details:
| Pack Size | 5 g |
| Pack Type | Tube |
| Strength | 2% |
| Brand Name | MEDROCINE OINTMENT |
| Manufacturer | MEDLOCK HEALTHCARE |
| Shelf Life | 24 MONTH |
| Country of Origin | Made in India |
Product Details:
| Strength | 600 mg |
| Packaging Size | 10x6 |
| Packaging Type | Box |
| Brand | MEDZOLIDE-600 |
| Manufacturer | MEDLOCK HEALTHCARE |
| Composition | Linezolid 600 Mg Tablet |
| Country of Origin | Made in India |
Product Details:
| Dose | 500 mg/ 2ml |
| Packaging Type | Vial |
| Form | Injection |
| Shelf life | 24 months |
| Prescription/Non prescription | Prescription |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Dose | 100 mg/ 2ml |
| Packaging Type | Vial |
| Form | Injection |
| Shelf life | 24 months |
| Prescription/Non prescription | Prescription |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Strength | 200 mg |
| Packaging Size | 10X10 |
| Packaging Type | Stripe |
| Manufacturer | MEDLOCK HEALTHCARE |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Dose/Strength | 200 mg / 500 mg |
| Packaging Size | 1x10 |
| Brand | LOXIMED-OZ |
| Packaging Type | Aluminium |
| Manufacturer | MEDLOCK HEALTHCARE |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Strength | 200 mg |
| Packaging Size | 10x10 Tablets |
| Packaging Type | Box |
| Country of Origin | Made in India |
| AVAILABLE | PCD PHARMA FRANCHISE |
| FROM | MEDLOCK HEALTHCARE |
| SHELF LIFE | 24 MONTH |
Product Details:
| Strength | 100 mg |
| Pack Size | 10*10 Capsule |
| Pack Type | Box |
| Brand | LOCPOD-100 TABLET |
| Manufactured By | MEDLOCK HEALTHCARE |
| Shelf Life | 24 Months |
| Country of Origin | Made in India |
| AVAILABLE | PCD PHARMA FRANCHISE |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Strength | 200 Mg |
| Packaging Type | Box |
| Packaging Size | 60 Tablets |
| Brand | MED-FEROPENEM 200 TABLET |
| Manufacturer | MEDLOCK HEALTHCARE |
| Shelf Life | 24 MONTH |
| Usage/Application | Hospital |
Product Details:
| Strength | 100mg/30ml |
| Pack Size | 30 ml |
| Brand | Medlock Healthcare |
| Dosage Form | Ready Syrup |
| Sugar Content | With Sugar |
| Pack Type | Bottle With Carton |
| Usage | Paediatric |
| Prescription | Prescription |
| Flavour | Strawberry |
| Country of Origin | India |
Azycap 100 Suspension is an effective antibiotic formulation containing Azithromycin, a broad-spectrum macrolide antibiotic. This medication is specifically designed to treat a variety of bacterial infections, making it a vital tool in combating illnesses caused by susceptible organisms. Azithromycin works by inhibiting bacterial protein synthesis, which ultimately halts bacterial growth and allows the immune system to effectively eliminate the infection.
This suspension is commonly prescribed for various conditions, including respiratory tract infections such as pneumonia and bronchitis, skin infections, and certain sexually transmitted infections. Its effectiveness against a wide range of bacteria makes it a preferred choice for healthcare providers when treating infections in both adults and children. The convenient suspension form ensures easy administration, particularly for pediatric patients or those who have difficulty swallowing tablets.
Azycap-100 Suspension is generally well-tolerated, with a dosing regimen that is often simpler than that of other antibiotics, typically requiring fewer doses over a shorter duration. This not only enhances patient compliance but also minimizes the risk of developing antibiotic resistance.
Product Details:
| Strength | 400 mg |
| Packaging Type | Alu-Alu |
| Packaging Size | 10*10 Tablets |
| Brand | RIFACARE 400 |
| Manufacturer | MEDLOCK HEALTHCARE |
| Shelf Life | 24 MONTHS |
| Available | PCD PHARMA FRANCHISE |
Product Details:
| Strength | 600 mg/4 ml |
| Packaging Size | 4 ml |
| Brand | clindaloc-600 injection |
| Composition | Clindamycin 600 mg |
| Route of Administration | IV/IM |
| Packaging Type | Glass ampoule |
| Shelf Life | 24 months |
| Prescription Type | Prescription |
| Country of Origin | India |
| Storage Condition | Below 25°C |
Clindaloc 600 Injection contains Clindamycin (600mg), a powerful lincosamide antibiotic used to treat various bacterial infections. Clindamycin works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth and preventing the spread of infection. It is particularly effective against Gram-positive bacteria and certain anaerobic pathogens.
This injectable formulation is often used in moderate to severe infections where oral antibiotics are not suitable, or for patients requiring rapid therapeutic action. It is widely utilized in the management of serious infections involving the respiratory tract, skin, soft tissues, bones, and joints. Clindamycin is also beneficial in treating intra-abdominal infections, pelvic inflammatory disease, and septicemia. Additionally, it is used as part of combination therapy in certain dental infections and post-operative prophylaxis to reduce the risk of infection.
Clindaloc 600 Injection is administered intravenously or intramuscularly under medical supervision. The dosage and duration depend on the type and severity of the infection and the patient's condition.
Product Details:
| Strength | 300 mg/2 ml |
| Packaging Size | 2 ml |
| Brand | Clindaloc-300 injection |
| Composition | Clindamycin 150 mg/ml |
| Route of Administration | IV/IM |
| Packaging Type | Glass ampoule |
| Shelf Life | 24 months |
| Prescription Type | Prescription |
| Country of Origin | India |
| Storage Condition | Below 25°C |
Clindaloc 300 Injection is a sterile, parenteral formulation containing clindamycin, a lincosamide antibiotic, at a concentration of 300 mg per vial. This medication is primarily indicated for the treatment of serious infections caused by anaerobic bacteria, as well as certain infections caused by susceptible strains of Gram-positive bacteria. Clindamycin works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of the bacteria.
Clindaloc is particularly effective in treating skin and soft tissue infections, respiratory tract infections, and infections of the female genital tract. It may also be used in combination with other antibiotics to enhance therapeutic efficacy in polymicrobial infections. The injection is typically administered intravenously or intramuscularly, depending on the clinical situation and the severity of the infection.
Product Details:
| Piperacillin strength | 1 gm |
| Tazobactam strength | 125 mg |
| Pack size | 1 vial |
| Usage | IV use |
| Form | Dry powder |
| Brand type | Pcd brand |
| Prescription | Prescription |
| Storage | Below 25 C |
| Shelf life | 24 months |
| Company type | Wholesaler, Pcd company |
MEDPEPZ 1.125 Injection combines Piperacillin (1000mg), a broad-spectrum penicillin antibiotic, and Tazobactam (125mg), a beta-lactamase inhibitor. This combination is designed to combat bacterial infections, including resistant strains, by disrupting bacterial cell wall synthesis and neutralizing beta-lactamase enzymes that confer antibiotic resistance.
Piperacillin acts by inhibiting the bacterial cell wall, leading to cell death. Tazobactam enhances its efficacy by preventing the breakdown of Piperacillin by beta-lactamase enzymes, ensuring robust action against Gram-positive, Gram-negative, and anaerobic bacteria. This synergy makes MEDPEPZ 1.125 Injection effective in treating a range of severe infections.
It is primarily indicated for managing hospital-acquired pneumonia, complicated urinary tract infections, intra-abdominal infections, sepsis, and skin and soft tissue infections. It is also effective in combating polymicrobial infections, especially in hospitalized or critically ill patients.
MEDPEPZ 1.125 Injection is administered via intravenous infusion under medical supervision, ensuring rapid action and optimal therapeutic outcomes. The combination provides broad-spectrum coverage, making it a preferred choice for empiric therapy in serious infections.
Healthcare providers must monitor patients during treatment to assess therapeutic response and manage any potential side effects. It is crucial to complete the prescribed course to prevent resistance development.
Product Details:
| Minimum Order Quantity | 500 Bottle |
| Packaging Size | 30 ml |
| Composition | Oflaxacin 50mg & Metronidazole120mg |
| Available | PCD PHARMA FRANCHISE |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Strength | 100 mg/2 ml |
| Packaging Size | 2 ml |
| Brand | Lomik-100 Injection |
| Dosage Form | Injection |
| Packaging Type | Vial |
| Prescription Type | Prescription |
| Shelf Life | 18 months |
| Storage Condition | Store below 25°C |
| Administration Route | IV or IM |
| Country of Origin | India |
Lomik-100 Injection contains Amikacin (100mg), a broad-spectrum antibiotic belonging to the aminoglycoside class. It is used to treat serious bacterial infections caused by gram-negative and some gram-positive bacteria. Lomik-100 Injection works by inhibiting bacterial protein synthesis, which leads to the death of the bacteria and halts the infection. This makes it highly effective in combating life-threatening infections, especially in hospital settings.
Amikacin is particularly beneficial for infections resistant to other antibiotics, including those in the respiratory tract, urinary tract, skin, soft tissues, abdominal infections, and bloodstream infections. Administered via injection, Lomik-100 ensures rapid and targeted action.
Its potent antibacterial properties make it a reliable choice for managing infections caused by pathogens such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. It is widely used under strict medical supervision to address conditions like sepsis, peritonitis, and complicated urinary tract infections.
Product Details:
| Strength | 500 mg |
| Volume | 10 ml |
| Brand | Azycap-500 |
| Composition | Azithromycin |
| Injection Type | Dry Powder |
| Route of Administration | IV infusion |
Azycap-500 Injection is a potent formulation containing azithromycin, a macrolide antibiotic, designed for parenteral administration. Azithromycin works by inhibiting bacterial protein synthesis, making it effective against a wide range of Gram-positive and Gram-negative bacteria. This medication is particularly beneficial for treating various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted diseases. Azycap is known for its excellent tissue penetration and long half-life, which allows for once-daily dosing, improving patient compliance.
The formulation is designed to ensure rapid absorption and effective concentration of the antibiotic in the bloodstream, allowing for a swift therapeutic response. Azycap is administered via intravenous injection, making it suitable for patients who may have difficulty with oral medications or require immediate treatment in a clinical setting.
Product Details:
| Piperacillin strength | 4 g |
| Tazobactam strength | 500 mg |
| Pack size | 1 vial |
| Usage | IV use |
| Form | Dry powder |
| Brand type | Pcd brand |
| Prescription | Prescription |
| Storage | Below 30 C |
| Shelf life | 24 months |
| Company type | Pcd company, Wholesaler |
MEDPEPZ 4.5 Injection is a robust antibiotic combination of Piperacillin (4000mg) and Tazobactam (500mg). This formulation is highly effective in treating a wide range of severe bacterial infections, including those caused by resistant strains.
Piperacillin is a broad-spectrum penicillin antibiotic that inhibits bacterial cell wall synthesis, leading to the destruction of the bacteria. Tazobactam, a beta-lactamase inhibitor, protects Piperacillin from enzymatic degradation by beta-lactamase-producing bacteria. Together, this combination extends the spectrum of antibacterial activity to cover Gram-positive, Gram-negative, and anaerobic bacteria, making it suitable for treating complex infections.
This medication is primarily indicated for the management of hospital-acquired pneumonia, complicated intra-abdominal infections, bloodstream infections (sepsis), complicated urinary tract infections, and skin and soft tissue infections. It is also frequently used as empirical therapy for critically ill patients due to its broad coverage.
Administered via intravenous infusion, MEDPEPZ 4.5 Injection ensures rapid delivery and effectiveness. Its use is typically restricted to healthcare settings where patients can be closely monitored for therapeutic response and any adverse reactions.
Product Details:
| Minimum Order Quantity | 50000 Box |
| Strength | 20 mg |
| Brand Name | VONPALOCK-20 |
| Packaging Size | 10x10 Tablets |
| Manufacturer | MEDLOCK HEALTHCARE |
| Dosage Form | Tablet |
| Packaging Type | Box |
| Composition | Vonoprazan |
Additional Information:
Product Details:
| Strength | 1500 mg |
| Packaging Size | 1.5 gm per Vial |
| Prescription/Non Prescription | Prescription |
| Country of origin | Made in India |
| FROM | MEDLOCK HEALTHCARE |
| AVAILABLE | PCD PHARMA FRANCHISE |